Zhuohan Hu

874 total citations
16 papers, 696 citations indexed

About

Zhuohan Hu is a scholar working on Oncology, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Zhuohan Hu has authored 16 papers receiving a total of 696 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Pharmacology and 6 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Zhuohan Hu's work include Drug Transport and Resistance Mechanisms (9 papers), Pharmacological Effects and Toxicity Studies (6 papers) and Pharmacogenetics and Drug Metabolism (5 papers). Zhuohan Hu is often cited by papers focused on Drug Transport and Resistance Mechanisms (9 papers), Pharmacological Effects and Toxicity Studies (6 papers) and Pharmacogenetics and Drug Metabolism (5 papers). Zhuohan Hu collaborates with scholars based in China, Japan and Canada. Zhuohan Hu's co-authors include Kazuya Maeda, Yuichi Sugiyama, Odd G. Nilsen, Bent H. Hellum, Hiroyuki Kusuhara, Yasuhisa Adachi, Takao Watanabe, Masakazu Hirouchi, Yoshikazu Saito and Hiroshi Kanamaru and has published in prestigious journals such as SHILAP Revista de lepidopterología, Molecules and Carcinogenesis.

In The Last Decade

Zhuohan Hu

15 papers receiving 665 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhuohan Hu China 8 456 340 246 94 71 16 696
Jingjing Yu United States 12 306 0.7× 349 1.0× 198 0.8× 160 1.7× 26 0.4× 23 852
Yuanfei Huang China 11 251 0.6× 229 0.7× 147 0.6× 124 1.3× 89 1.3× 18 607
Masayuki Tsujimoto Japan 19 623 1.4× 338 1.0× 316 1.3× 289 3.1× 74 1.0× 76 1.3k
Martine Lebot France 8 202 0.4× 276 0.8× 123 0.5× 94 1.0× 119 1.7× 10 660
Jianghua Tu China 13 197 0.4× 243 0.7× 129 0.5× 167 1.8× 44 0.6× 17 582
R B Kim United States 8 697 1.5× 366 1.1× 333 1.4× 256 2.7× 49 0.7× 8 1.1k
Susan Wong United States 17 248 0.5× 314 0.9× 98 0.4× 220 2.3× 35 0.5× 39 833
Er‐jia Wang China 11 333 0.7× 186 0.5× 147 0.6× 158 1.7× 25 0.4× 13 685
R Temple United States 4 192 0.4× 261 0.8× 114 0.5× 113 1.2× 28 0.4× 5 554

Countries citing papers authored by Zhuohan Hu

Since Specialization
Citations

This map shows the geographic impact of Zhuohan Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhuohan Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhuohan Hu more than expected).

Fields of papers citing papers by Zhuohan Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhuohan Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhuohan Hu. The network helps show where Zhuohan Hu may publish in the future.

Co-authorship network of co-authors of Zhuohan Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhuohan Hu. A scholar is included among the top collaborators of Zhuohan Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhuohan Hu. Zhuohan Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Hu, Zhuohan, Zhongqin Wu, Yan Li, et al.. (2025). In Vitro Inhibitory Effects and Molecular Mechanism of Four Theaflavins on Isozymes of CYP450 and UGTs. Foods. 14(16). 2822–2822.
2.
Mao, Junjun, et al.. (2024). In vitro mechanistic study on mycophenolate mofetil drug interactions: effect of prednisone, cyclosporine, and others. Frontiers in Pharmacology. 15. 1443794–1443794. 2 indexed citations
3.
Hu, Zhuohan, et al.. (2022). Metabolism-mediated drug–drug interactions – Study design, data analysis, and implications for in vitro evaluations. SHILAP Revista de lepidopterología. 14. 100121–100121. 7 indexed citations
4.
Xu, Qing, Wei Wu, Yi Sun, et al.. (2021). Metabolism and transporter based drug–drug interaction of tacrolimus with nine co-medicated injections. SHILAP Revista de lepidopterología. 10. 100091–100091. 2 indexed citations
5.
Fu, Shujun, Feifei Yu, Tao Sun, & Zhuohan Hu. (2021). Transporter-mediated drug–drug interactions – Study design, data analysis, and implications for in vitro evaluations. SHILAP Revista de lepidopterología. 11. 100096–100096. 7 indexed citations
6.
7.
Hu, Zhuohan. (2012). Enhanced anti-HIV efficacy of indinavir by metabolic interactions with the traditional Chinese medicine prescription ZYSH. Zhongguo xin yao zazhi. 2 indexed citations
8.
Hu, Zhuohan. (2012). Inhibitory action of "Jiangzhi Decoction" on isozyme 3A4 of cytchrome P450. Shanghai Journal of Traditional Chinese Medicine. 1 indexed citations
9.
Watanabe, Takao, Hiroyuki Kusuhara, Tomoko Watanabe, et al.. (2011). Prediction of the Overall Renal Tubular Secretion and Hepatic Clearance of Anionic Drugs and a Renal Drug-Drug Interaction Involving Organic Anion Transporter 3 in Humans by In Vitro Uptake Experiments. Drug Metabolism and Disposition. 39(6). 1031–1038. 75 indexed citations
10.
Watanabe, Takao, Hiroyuki Kusuhara, Kazuya Maeda, et al.. (2009). Investigation of the Rate-Determining Process in the Hepatic Elimination of HMG-CoA Reductase Inhibitors in Rats and Humans. Drug Metabolism and Disposition. 38(2). 215–222. 159 indexed citations
11.
Hellum, Bent H., Zhuohan Hu, & Odd G. Nilsen. (2009). Trade Herbal Products and Induction of CYP2C19 and CYP2E1 in Cultured Human Hepatocytes. Basic & Clinical Pharmacology & Toxicology. 105(1). 58–63. 30 indexed citations
12.
Yamada, Akihiro, Kazuya Maeda, Emi Kamiyama, et al.. (2007). Multiple Human Isoforms of Drug Transporters Contribute to the Hepatic and Renal Transport of Olmesartan, a Selective Antagonist of the Angiotensin II AT1-Receptor. Drug Metabolism and Disposition. 35(12). 2166–2176. 111 indexed citations
13.
Hellum, Bent H., Zhuohan Hu, & Odd G. Nilsen. (2006). The Induction of CYP1A2, CYP2D6 and CYP3A4 by Six Trade Herbal Products in Cultured Primary Human Hepatocytes. Basic & Clinical Pharmacology & Toxicology. 100(1). 23–30. 102 indexed citations
14.
Maeda, Kazuya, et al.. (2006). INVOLVEMENT OF TRANSPORTERS IN THE HEPATIC UPTAKE AND BILIARY EXCRETION OF VALSARTAN, A SELECTIVE ANTAGONIST OF THE ANGIOTENSIN II AT1-RECEPTOR, IN HUMANS. Drug Metabolism and Disposition. 34(7). 1247–1254. 163 indexed citations
15.
16.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jingjing Yu Breakdown of academic impact, for papers by Yuanfei Huang Breakdown of academic impact, for papers by Masayuki Tsujimoto Breakdown of academic impact, for papers by Martine Lebot Breakdown of academic impact, for papers by Jianghua Tu Breakdown of academic impact, for papers by R B Kim Breakdown of academic impact, for papers by Susan Wong Breakdown of academic impact, for papers by Er‐jia Wang Breakdown of academic impact, for papers by R Temple
Rankless by CCL
2026